viimane versioon :
19/11/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Ascorbic acid
keemiline struktuur
Kaubanduslikud nimed erinevates maades
Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist
Acido ascorbico
Ecuador, Kolumbia, Tšiili, Venetsueela
Acmel
Türgi
Adeene vitamina C
Argentiina
Amsac
Mehhiko
Ascorbic acid
Araabia Ühendemiraadid, Austraalia, Suurbritannia, uus-Meremaa
Ascorbil
Maroko
Ascorbinezuur
Holland
Ascorell
Saksamaa
Ascorvit
Saksamaa
Bio C
Maroko
C Viton
Egiptus
Cebion
Saksamaa
Cemin
Ecuador
Cevalin
Mehhiko
Cevarol
Egiptus
Cevitol
Austria
Infalet
Mehhiko
Laperox
Mehhiko
Laroscorbine
Maroko, Prantsusmaa
Mega C acid
Kanada
Mel C
Austria
Osve vitamin C
Iraan
Pascorbin
Ecuador
Synum
Saksamaa
Viciforte
Itaalia
Vitamedic
Rumeenia
Vitamin C
Austria, Iraan, Kanada, Saksamaa, Ungari
Vitamina C
Argentiina, Itaalia, Kolumbia, Rumeenia, Venetsueela
Vitamine C
Sveits
Vitaminum C
Poola
Viited : Ascorbic acid
tüüp
avaldamine
319
ajaleht
Hadzija BW, Lubarsky DA.
Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia.
Am J Health-Syst Pharm 1995 ; 52: 997-999.
552
ajaleht
Martinez JF, Trissel LA, Gilbert DL.
Compatibility of warfarin sodium with selected drugs and large-volume parenteral solutions.
Int J Pharm Compound 1997 ; 1: 356-358.
939
ajaleht
Gilbar PJ, Groves CF.
Visual compatibility of total parenteral nutrition solution (Synthamin 17 Premix*) with selected drugs during simulated Y-site injection.
Aust J Hosp Pharm 1994 ; 24: 167-170.
1057
ajaleht
Cutie MR.
Compatibility of verapamil hydrochloride injection with commonly used additives.
Am J Hosp Pharm 1983 ; 40: 1205-1207.
1995
ajaleht
Chin A, Liu S, Ting-Chan J, Gill MA.
Extended stability of ascorbic acid in 5% dextrose injection and 0.9% sodium chloride injection.
Am J Health-Syst Pharm 2005 ; 62: 1073-1074.
3128
Labor
Mitomycine (Amétycine®) - Résumé Caractéristiques du Produit
Prostrakan 2013
3549
Labor
Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3588
Labor
Vancomycine (Vancocin®) - Résumé des caractéristiques du produit
Sandoz 2011
3646
Labor
Bléomycine sulfate (Bléomycine Bellon®) - Résumé des caractéristiques du produit
Sanofi Aventis France 2013
3674
Labor
Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
3932
Labor
Hydroxocobalamine (Cyanokit®) - Résumé des caractéristiques du produit
Serb Laboratoire 2015
4154
Labor
Bleomycin sulfate- Summary of Product Characteristics
Accord Health Care 2018
4245
plakat
Iazetta J, Law S, Adhikari NKJ, Lamontagne F, Kanji S, Walker SE.
Physical Compatibility and Stability of Ascorbic acid Injection in Polyvinyl Chloride Minibags at 4ºC and Room Temperature (25ºC).
2019
4471
Labor
Amétycine 10 mg poudre pour solution injectable - Résumé des caractéristiques du produit - Oct 10, 2019
Kyowa Kirin Pharma 2019
4510
ajaleht
Stawny M, Gostyńska A, Olijarczyk R, Dettlaff K, Jelińska A, Ogrodowczyk M.
Stability studies of parenteral nutrition with a high dose of vitamin C.
J Oncol Pharm Practice 2020 ;26,8:1894–1902
Mentions Légales